Suicide effect on rat gliomas mediated by recombinant adenovirus thymidine kinase/acyclovir system.
OBJECTIVE
To establish the replicated-deficient recombinant adenovirus-mediated thymidine kinase/acyclovir (Adtk/ACV) system and to evaluate its suicide effect on rat C6 brain gliomas in vitro and in vivo.


METHODS
The plasmid pAdtk and pJM17 were co-infected into 293 cells (adenovector packaging cells) and the results were identified by polymerase chain reaction (PCR) assay. After the glioma C6 cells were transduced by Adtk at different multiplicity of infection (MOI) and exposed to different concentrations of ACV or gancyclovir (GCV), the cell survival curves were studied, and the cell surface was observed with scanning electronic microscopy (SEM). C6 gliomas in vivo at different inoculation days were injected with Adtk intratumorally and ACV intraperitoneally daily, and the survival duration and histologic changes of the rats were observed.


RESULTS
The infectious Adtk virions had a suicide effect which was enhanced with the increase in MOIs of Adtk and ACV doses along with bystander effect. Under scanning electronic microscope, special pathologic changes were observed. ACV had a similar effect as GCV but a higher dose was used. The survival duration in day 3, day 6 and day 8 groups exceeded 90 days, and the rats in day 10 group survived 28.5 +/- 4.6 days, but the survival duration in untreated C6 group and AdLacZ/ACV (adenovirus-mediated LacZ/ACV) treated group were 16.8 +/- 3.1 and 14.0 +/- 2.2 days respectively.


CONCLUSIONS
Adtk/ACV system can effectively kill the rat brain gliomas in vitro and in vivo.
Wang
Q
Q
Institute of Genetics, Fudan University, Shanghai 200433, China.
Lu
D
D
Xing
Y
Y
Xue
J
J
Qiu
X
X
D000212:Acyclovir / Q000494:pharmacology*; D000260:Adenoviruses, Human / Q000201:enzymology / Q000235:genetics; D000818:Animals; D001932:Brain Neoplasms / Q000473:pathology* / Q000628:therapy; D015774:Ganciclovir / Q000494:pharmacology; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005910:Glioma / Q000473:pathology* / Q000628:therapy; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000494:pharmacology; D013937:Thymidine Kinase / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D011994:Recombinant Proteins; D013937:Thymidine Kinase; D015774:Ganciclovir; D000212:Acyclovir